Literature DB >> 12356803

Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis.

Albert Sotto1, Jean Yves Lefrant, Pascale Fabbro-Peray, Laurent Muller, Jérôme Tafuri, Francis Navarro, Michel Prudhomme, Jean Emmanuel De La Coussaye.   

Abstract

OBJECTIVES: To evaluate antimicrobial therapy management of secondary peritonitis in a University Hospital. PATIENTS AND METHODS: All patients admitted to the intensive care unit of the University Hospital of Nîmes from 1 January 1997 to 31 July 1999 with a diagnosis of secondary peritonitis were retrospectively included. Patients' medical records were collected from the data recordings of the Department of Critical Care and Emergency and the Departments of Surgery. Acute Physiology and Chronic Health Evaluation II (APACHE II) was calculated for each patient at the time of admission. Antimicrobial treatment management before and after the diagnosis of peritonitis was studied.
RESULTS: One hundred and twenty patients were included. Results concerning mortality, aetiology of peritonitis and microbiological data were in accordance with previous studies. APACHE II score (P = 0.005), age (P = 0.002), presence of Enterococcus in the peri-operative samples (P = 0.02) and period between diagnosis and surgery (P = 0.04) were predictive of death within 30 days after diagnosis of peritonitis. No significant difference was shown in the mortality rate in patients whose post-operative antibiotic treatment was changed following results of intra-operative peritoneal cultures versus patients having inappropriate treatment (P = 0.96). The same observations were noted for anti-enterococcal treatment.
CONCLUSION: This study emphasizes the importance of prompt surgical treatment and shows the modest impact of adapting antibiotic treatment. The morbidity and mortality associated with the presence of Enterococcus, which was not influenced by antibiotic treatment, would seem to suggest the pro-inflammatory role of Enterococcus. However, prospective randomized studies are needed to evaluate the real contribution of enterococcal antibiotic coverage in this context.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356803     DOI: 10.1093/jac/dkf167

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  28 in total

1.  Are enterococci playing a role in postoperative peritonitis in critically ill patients?

Authors:  P Seguin; C Brianchon; Y Launey; B Laviolle; N Nesseler; P-Y Donnio; Y Malledant
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-12       Impact factor: 3.267

Review 2.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

3.  Profiling of Candida albicans gene expression during intra-abdominal candidiasis identifies biologic processes involved in pathogenesis.

Authors:  Shaoji Cheng; Cornelius J Clancy; Wenjie Xu; Frank Schneider; Binghua Hao; Aaron P Mitchell; M Hong Nguyen
Journal:  J Infect Dis       Date:  2013-09-04       Impact factor: 5.226

4.  The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis.

Authors:  J de Ruiter; J Weel; E Manusama; W P Kingma; P H J van der Voort
Journal:  Infection       Date:  2009-12       Impact factor: 3.553

5.  Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

Authors:  Cheol-In Kang; Sung-Han Kim; Wan Beom Park; Ki-Deok Lee; Hong-Bin Kim; Eui-Chong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 6.  Critical issues in the clinical management of complicated intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis.

Authors:  Pascal Augustin; Nathalie Kermarrec; Claudette Muller-Serieys; Sigismond Lasocki; Denis Chosidow; Jean-Pierre Marmuse; Nadia Valin; Jean-Marie Desmonts; Philippe Montravers
Journal:  Crit Care       Date:  2010-02-15       Impact factor: 9.097

Review 8.  Are there patients with peritonitis who require empiric therapy for enterococcus?

Authors:  S Harbarth; I Uckay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-21       Impact factor: 3.267

Review 9.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis.

Authors:  Florence C Riché; Xavier Dray; Marie-Josèphe Laisné; Joaquim Matéo; Laurent Raskine; Marie-José Sanson-Le Pors; Didier Payen; Patrice Valleur; Bernard P Cholley
Journal:  Crit Care       Date:  2009-06-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.